Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD  |  Issue: March 2013  |  March 1, 2013

Most genetic changes associated with disease do not occur in protein-coding regions of DNA, but in their regulatory regions. Clearly, there is more to the genetics of a particular disease than simply identifying its critical genes. DNA methylation may be one of the key players working behind the scenes to determine whether a disease is phenotypically expressed or remains clinically dormant, locked inside the host’s genetic code. Fortuitously, this interesting work was published around the time of Faye’s visit; she left my office without a prescription (she didn’t need one) but armed with a copy of the paper’s abstract.

Lessons Learned

The term “nature versus nurture” was coined by Francis Galton, a cousin of Charles Darwin, to reflect the balance between heredity and environment on social advancement. Yet this term can apply to virtually all aspects of clinical medicine. The great mystery of why some people become ill and others stay healthy is slowly being unraveled. We are only beginning to observe and understand how environmental stresses can influence the genetics and the phenotype of autoimmune diseases. I think Darwin would have loved rheumatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Helfgott is physician editor of The Rheumatologist and associate professor of medicine in the division of rheumatology, immunology, and allergy at Harvard Medical School in Boston.

References

  1. Newman AA. A healing touch from hospitals. New York Times. September 13, 2011. P B2. Available at www.nytimes.com/2011/09/13/business/health-care-ad-spending-rises-advertising.html. Accessed February 13, 2013.
  2. Reuben A. Praise ye the god of iron. Hepatology. 2004;40:1231-1234.
  3. First U.S. scientist to die of plague in 50 years worked in labs with ‘harmless’ bacteria. Daily Mail Online. February 28, 2011. Available at www.dailymail.co.uk/sciencetech/article-1360783/Malcolm-Casadaban-U-S-scientist-die-plague-50-years.html. Accessed February 13, 2013.
  4. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload–related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358:221-230.
  5. Morris KV. Lamarck and the missing lnc. The Scientist. October 1, 2012. Available at www.the-scientist.com/?articles.view/articleNo/32637/title/Lamarck-and-the-Missing-Lnc. Accessed February 13, 2013.
  6. Franklin TB, Mansuy IM. Epigenetic inheritance in mammals: Evidence for the impact of adverse environmental effects. Neurobiol Dis. 2010;39:61-65.
  7. Soubry A, Schildkraut JM, Murtha A, et al. Obesity is associated with IGF2 hypomethylation in newborns: Results from a Newborn Epigenetics Study (NEST) cohort. BMC Medicine. 2013;11:29.
  8. Klareskog L, L Alfredsson L, Rantapää-Dahlqvist S, et al. What precedes development of rheumatoid arthritis? Ann Rheum Dis. 2004;63(Suppl 2):ii28–ii31.
  9. Liu, Y, Aryee MJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotecnol. 2013;31:142-147.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:epigeneticsResearchRheumatic Disease

Related Articles
    Kateryna Kon / Shutterstock.com

    How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

    December 17, 2017

    Anemia is common in patients with systemic rheumatic disease, yet it may not get the attention it deserves. Anemia can result from chronic inflammation, treatment side effects or other disease factors, or it may signal an unrelated condition. Although diagnosis and treatment of anemia are sometimes challenging, clinicians must do their utmost to rigorously investigate…

    The Latest on Epigenetics in Immune-Mediated Disease

    March 19, 2019

    CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences